TNF and Crohn disease: Furthermore, another retrospective study in which anti-TNF agents were used in larger therapeutic doses for up to 10 years in a very small group of patients with rheumatoid arthritis and Crohn's disease resulted in significantly better glycemic control in patients with coexistent type 2 diabetes [22].